Literature DB >> 31470314

Management of locally recurrent nasopharyngeal carcinoma.

Anne W M Lee1, Wai Tong Ng2, Jimmy Y W Chan3, June Corry4, Antti Mäkitie5, William M Mendenhall6, Alessandra Rinaldo7, Juan P Rodrigo8, Nabil F Saba9, Primož Strojan10, Carlos Suárez11, Jan B Vermorken12, Sue S Yom13, Alfio Ferlito14.   

Abstract

As a consequence of the current excellent loco-regional control rates attained using the generally accepted treatment paradigms involving intensity-modulated radiotherapy for nasopharyngeal carcinoma (NPC), only 10-20% of patients will suffer from local and/or nodal recurrence after primary treatment. Early detection of recurrence is important as localized recurrent disease is still potentially salvageable, but this treatment often incurs a high risk of major toxicities. Due to the possibility of radio-resistance of tumors which persist or recur despite adequate prior irradiation and the limited tolerance of adjacent normal tissues to sustain further additional treatment, the management of local failures remains one of the greatest challenges in this disease. Both surgical approaches for radical resection and specialized re-irradiation modalities have been explored. Unfortunately, available data are based on retrospective studies, and the majority of them are based on a small number of patients or relatively short follow-up. In this article, we will review the different salvage treatment options and associated prognostic factors for each of them. We will also propose a treatment algorithm based on the latest available evidence and discuss the future directions of treatment for locally recurrent NPC.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Nasopharyngeal carcinoma; Nasopharyngectomy; Prognostic factor; Radiotherapy; Recurrent

Mesh:

Year:  2019        PMID: 31470314     DOI: 10.1016/j.ctrv.2019.101890

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  53 in total

1.  Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.

Authors:  Guang Ma; Bingxin Gu; Jiyi Hu; Lin Kong; Jiangang Zhang; Zili Li; Yangbo Xue; Jiade Lu; Junning Cao; Jingyi Cheng; Yingjian Zhang; Shaoli Song; Zhongyi Yang
Journal:  Ann Nucl Med       Date:  2021-04-28       Impact factor: 2.668

2.  Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR.

Authors:  Yongfeng Piao; Caineng Cao; Yuanfan Xu; Shuang Huang; Feng Jiang; Ting Jin; Qifeng Jin; Yonghong Hua; Qiaoying Hu; Xiaozhong Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-29       Impact factor: 2.503

3.  Circ_0028007 Aggravates the Malignancy of Nasopharyngeal Carcinoma by Regulating miR-656-3p/ELF2 Axis.

Authors:  Xiaojun Ma; Yan Li
Journal:  Biochem Genet       Date:  2022-03-03       Impact factor: 1.890

4.  Longitudinal evaluation of five nasopharyngeal carcinoma animal models on the microPET/MR platform.

Authors:  Jingjing Shi; Zhichao Xue; Kel Vin Tan; Hui Yuan; Anna Chi Man Tsang; Sai Wah Tsao; Pek-Lan Khong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-04       Impact factor: 9.236

5.  Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Authors:  Weihong Luan; Haozhan Yuan; Wei Hou; Jing Li; Liping Liu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

6.  Incidence and mortality trends of nasopharynx cancer from 1990 to 2019 in China: an age-period-cohort analysis.

Authors:  Ruhai Bai; Jianzhong Sun; Yan Xu; Zhonghe Sun; Xiaoyan Zhao
Journal:  BMC Public Health       Date:  2022-07-15       Impact factor: 4.135

Review 7.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

8.  Novel long non-coding RNA lncAMPC downregulates PTEN via miR-214 to promote nasopharyngeal carcinoma progression.

Authors:  Xianqing Li; Shunlin Ouyang
Journal:  Mol Cell Biochem       Date:  2022-01-21       Impact factor: 3.396

9.  Balloon Test Occlusion of Internal Carotid Artery in Recurrent Nasopharyngeal Carcinoma Before Endoscopic Nasopharyngectomy: A Single Center Experience.

Authors:  Renhao Yang; Hui Wu; Binghong Chen; Wenhua Sun; Xiang Hu; Tianwei Wang; Yubin Guo; Yongming Qiu; Jiong Dai
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

Review 10.  The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application.

Authors:  Huidan Luo; Bin Yi
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.